Literature DB >> 19760337

A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model.

Amee J George1, Lavinia Gordon, Tim Beissbarth, Irene Koukoulas, R M Damian Holsinger, Victoria Perreau, Roberto Cappai, Seong-Seng Tan, Colin L Masters, Hamish S Scott, Qiao-Xin Li.   

Abstract

Serial analysis of gene expression (SAGE), a technique that allows for the simultaneous detection of expression levels of the entire genome without a priori knowledge of gene sequences, was used to examine the transcriptional expression pattern of the Tg2576 mouse model of Alzheimer's disease (AD). Pairwise comparison between the Tg2576 and nontransgenic SAGE libraries identified a number of differentially expressed genes in the Tg2576 SAGE library, some of which were not previously revealed by the microarray studies. Real-time PCR was used to validate a panel of genes selected from the SAGE analysis in the Tg2576 mouse brain, as well as the hippocampus and temporal cortex of sporadic AD and normal age-matched controls. NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 (NDUFA5) and FXYD domain-containing ion transport regulator 6 (FXYD6) were found to be significantly decreased in the Tg2576 mouse brain and AD hippocampus. PTEN-induced putative kinase 1 (PINK1), phosphatidylethanolamine binding protein (PEBP), crystalline mu (CRYM), and neurogranin (NRGN) were significantly decreased in AD tissues. The gene ontologies represented in the Tg2576 data were statistically analyzed and demonstrated a significant under-representation of genes involved with G-protein-coupled receptor signaling and odorant binding, while genes significantly over-represented were focused on cellular communication and cellular physiological processes. The novel approach of profiling the Tg2576 mouse brain using SAGE has identified different genes that could subsequently be examined for their potential as peripheral diagnostic and prognostic markers for Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760337     DOI: 10.1007/s12640-009-9112-3

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  90 in total

1.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

2.  APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.

Authors:  Walter Kalback; M Desiree Watson; Tyler A Kokjohn; Yu-Min Kuo; Nicole Weiss; Dean C Luehrs; John Lopez; Daniel Brune; Sangram S Sisodia; Matthias Staufenbiel; Mark Emmerling; Alex E Roher
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

3.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Authors:  A McShea; P L Harris; K R Webster; A F Wahl; M A Smith
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling.

Authors:  L Emilsson; P Saetre; E Jazin
Journal:  Neurobiol Dis       Date:  2005-10-27       Impact factor: 5.996

5.  Ontogeny of aquaporins 1 and 3 in ovine placenta and fetal membranes.

Authors:  H Johnston; I Koukoulas; K Jeyaseelan; A Armugam; L Earnest; R Baird; N Dawson; T Ferraro; E M Wintour
Journal:  Placenta       Date:  2000-01       Impact factor: 3.481

Review 6.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

7.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Authors:  T Kawarabayashi; L H Younkin; T C Saido; M Shoji; K H Ashe; S G Younkin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 9.  FXYD proteins: new tissue- and isoform-specific regulators of Na,K-ATPase.

Authors:  Käthi Geering; Pascal Béguin; Haim Garty; Steven Karlish; Maria Füzesi; Jean-Daniel Horisberger; Gilles Crambert
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

10.  Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

Authors:  Suzana Gispert; Filomena Ricciardi; Alexander Kurz; Mekhman Azizov; Hans-Hermann Hoepken; Dorothea Becker; Wolfgang Voos; Kristina Leuner; Walter E Müller; Alexei P Kudin; Wolfram S Kunz; Annabelle Zimmermann; Jochen Roeper; Dirk Wenzel; Marina Jendrach; Moisés García-Arencíbia; Javier Fernández-Ruiz; Leslie Huber; Hermann Rohrer; Miguel Barrera; Andreas S Reichert; Udo Rüb; Amy Chen; Robert L Nussbaum; Georg Auburger
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

View more
  31 in total

1.  Impact of common regulatory single-nucleotide variants on gene expression profiles in whole blood.

Authors:  Divya Mehta; Katharina Heim; Christian Herder; Maren Carstensen; Gertrud Eckstein; Claudia Schurmann; Georg Homuth; Matthias Nauck; Uwe Völker; Michael Roden; Thomas Illig; Christian Gieger; Thomas Meitinger; Holger Prokisch
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

2.  Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.

Authors:  Katalin Völgyi; Krisztina Háden; Viktor Kis; Péter Gulyássy; Kata Badics; Balázs András Györffy; Attila Simor; Zoltán Szabó; Tamás Janáky; László Drahos; Árpád Dobolyi; Botond Penke; Gábor Juhász; Katalin Adrienna Kékesi
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

3.  Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile.

Authors:  Francesca Crobu; Veronica Latini; Maria Franca Marongiu; Valeria Sogos; Franca Scintu; Susanna Porcu; Carla Casu; Manuela Badiali; Adele Sanna; Maria Francesca Manchinu; Maria Serafina Ristaldi
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

4.  Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.

Authors:  Sarah C Hopp; Nathan A Bihlmeyer; John P Corradi; Charles Vanderburg; Angela M Cacace; Sudeshna Das; Timothy W Clark; Rebecca A Betensky; Bradley T Hyman; Eloise Hudry
Journal:  J Neurochem       Date:  2018-09-07       Impact factor: 5.372

5.  Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes.

Authors:  Joungil Choi; Avinash Ravipati; Vamshi Nimmagadda; Manfred Schubert; Rudolph J Castellani; James W Russell
Journal:  Mitochondrion       Date:  2014-09-23       Impact factor: 4.160

6.  PINK1 Silencing Modifies Dendritic Spine Dynamics of Mouse Hippocampal Neurons.

Authors:  C J Hernández; C Báez-Becerra; M J Contreras-Zárate; H Arboleda; G Arboleda
Journal:  J Mol Neurosci       Date:  2019-09-05       Impact factor: 3.444

7.  Neurogranin alters the structure and calcium binding properties of calmodulin.

Authors:  Laurel Hoffman; Anuja Chandrasekar; Xu Wang; John A Putkey; M Neal Waxham
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

Review 8.  Lysine metabolism in mammalian brain: an update on the importance of recent discoveries.

Authors:  André Hallen; Joanne F Jamie; Arthur J L Cooper
Journal:  Amino Acids       Date:  2013-09-17       Impact factor: 3.520

Review 9.  Imine reductases: a comparison of glutamate dehydrogenase to ketimine reductases in the brain.

Authors:  André Hallen; Joanne F Jamie; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2013-01-12       Impact factor: 3.996

10.  Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.

Authors:  Maartje I Kester; Charlotte E Teunissen; Daniel L Crimmins; Elizabeth M Herries; Jack H Ladenson; Philip Scheltens; Wiesje M van der Flier; John C Morris; David M Holtzman; Anne M Fagan
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.